Tibolone + Estradiol + Estradiol + Medroxy Progesterone Acetate
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
80
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Postmenopause
Conditions
Postmenopause, Osteoporosis
Trial Timeline
Feb 1, 2003 โ Mar 1, 2005
NCT ID
NCT00294463About Tibolone + Estradiol + Estradiol + Medroxy Progesterone Acetate
Tibolone + Estradiol + Estradiol + Medroxy Progesterone Acetate is a approved stage product being developed by Organon for Postmenopause. The current trial status is completed. This product is registered under clinical trial identifier NCT00294463. Target conditions include Postmenopause, Osteoporosis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
5
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00294463 | Approved | Completed |
Competing Products
16 competing products in Postmenopause